Baxter price target raised to $53 from $52 at KeyBanc

KeyBanc raised the firm’s price target on Baxter to $53 from $52 and keeps an Overweight rating on the shares. The firm is encouraged numbers are starting their climb back up after multiple resets last year, although its capital equipment commentary seemed incrementally negative, the analyst tells investors in a research note.